Published in Oncogene on September 04, 1997
Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia (2010) 2.21
Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways. J Cell Biol (1999) 1.80
EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. Cancer Res (2009) 1.79
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. J Clin Oncol (2008) 1.65
Cellular responses to EGFR inhibitors and their relevance to cancer therapy. Cancer Lett (2007) 1.62
Increased phosphorylated extracellular signal-regulated kinase immunoreactivity associated with proliferative and morphologic lung alterations after chrysotile asbestos inhalation in mice. Am J Pathol (2000) 1.59
Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol Cancer (2008) 1.49
The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol (2008) 1.37
Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results. Invest New Drugs (1999) 1.34
Roles of the transcription factors snail and slug during mammary morphogenesis and breast carcinoma progression. J Mammary Gland Biol Neoplasia (2004) 1.33
Nuclear EGFR as a molecular target in cancer. Radiother Oncol (2013) 1.33
Cytokines in radiobiological responses: a review. Radiat Res (2012) 1.29
Targeting inflammatory pathways for tumor radiosensitization. Biochem Pharmacol (2010) 1.22
Links between innate immunity and normal tissue radiobiology. Radiat Res (2010) 1.19
ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model. Br J Cancer (2002) 1.18
Mechanism of short-term ERK activation by electromagnetic fields at mobile phone frequencies. Biochem J (2007) 1.16
EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib. Neuro Oncol (2006) 1.11
Noninvasive imaging and quantification of epidermal growth factor receptor kinase activation in vivo. Cancer Res (2008) 1.09
ATM-NF-kappaB connection as a target for tumor radiosensitization. Curr Cancer Drug Targets (2007) 1.06
Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells. Mol Biol Cell (2002) 1.06
Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776. J Biol Chem (2012) 1.04
SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus. BMC Cancer (2011) 1.04
Epidermal growth factor receptor and bladder cancer. Postgrad Med J (2002) 1.02
Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function. Strahlenther Onkol (2009) 1.01
Regulation of Caenorhabditis elegans p53/CEP-1-dependent germ cell apoptosis by Ras/MAPK signaling. PLoS Genet (2011) 1.00
Erlotinib in the treatment of advanced pancreatic cancer. Biologics (2008) 0.98
EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors? Br J Cancer (2012) 0.98
Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer. BMC Cancer (2005) 0.98
EGFR signaling and autophagy dependence for growth, survival, and therapy resistance. Cell Cycle (2013) 0.97
HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer. Anticancer Res (2007) 0.96
Role of cell cycle in epidermal growth factor receptor inhibitor-mediated radiosensitization. Cancer Res (2009) 0.96
Opportunities and challenges of radiotherapy for treating cancer. Nat Rev Clin Oncol (2015) 0.95
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol (2008) 0.95
Combination of radiotherapy with EGFR antagonists for head and neck carcinoma. Int J Clin Oncol (2007) 0.91
DNA double-strand break - induced pro-survival signaling. Radiother Oncol (2011) 0.90
Lessons learned from radiation oncology clinical trials. Clin Cancer Res (2013) 0.89
Additive interaction of gefitinib ('Iressa', ZD1839) and ionising radiation in human tumour cells in vitro. Br J Cancer (2004) 0.88
Nonmuscle myosin II is required for internalization of the epidermal growth factor receptor and modulation of downstream signaling. J Biol Chem (2012) 0.87
Integrin signalling and the cellular response to ionizing radiation. J Mol Histol (2004) 0.87
Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society. J Cancer Res Clin Oncol (2013) 0.87
Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 0.86
Cross talk of tyrosine kinases with the DNA damage signaling pathways. Nucleic Acids Res (2015) 0.86
Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma. Mol Oncol (2014) 0.85
Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization. Breast Cancer Res (2003) 0.84
Threonine 2609 phosphorylation of the DNA-dependent protein kinase is a critical prerequisite for epidermal growth factor receptor-mediated radiation resistance. Mol Cancer Res (2012) 0.84
Ionizing radiation induces tumor cell lysyl oxidase secretion. BMC Cancer (2014) 0.83
Roles for basal and stimulated p21(Cip-1/WAF1/MDA6) expression and mitogen-activated protein kinase signaling in radiation-induced cell cycle checkpoint control in carcinoma cells. Mol Biol Cell (1999) 0.83
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors. Onco Targets Ther (2016) 0.82
Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer. Int J Radiat Oncol Biol Phys (2008) 0.82
Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells. Mol Cancer (2013) 0.82
AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo. Invest New Drugs (2010) 0.82
The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models. Invest New Drugs (2012) 0.81
Modifying radiation damage. Curr Drug Targets (2010) 0.81
[Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma]. Strahlenther Onkol (2012) 0.81
Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities. Onco Targets Ther (2013) 0.81
Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck. Transl Oncol (2014) 0.80
Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan. Int J Clin Oncol (2008) 0.80
Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck. Onco Targets Ther (2009) 0.80
Inhibition of radiation-induced DNA repair and prosurvival pathways contributes to vorinostat-mediated radiosensitization of pancreatic cancer cells. Pancreas (2010) 0.80
Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer. Front Oncol (2016) 0.79
Radiation induces acute alterations in neuronal function. PLoS One (2012) 0.79
EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection. Pharmacol Ther (2015) 0.79
A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer. Front Oncol (2012) 0.78
Cetuximab may inhibit tumor growth and angiogenesis induced by ionizing radiation: a preclinical rationale for maintenance treatment after radiotherapy. Oncologist (2010) 0.78
Low-dose photon irradiation alters cell differentiation via activation of hIK channels. Pflugers Arch (2014) 0.77
Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines. Br J Cancer (2005) 0.77
Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling. Mol Cancer Ther (2015) 0.76
Linking the history of radiation biology to the hallmarks of cancer. Radiat Res (2014) 0.76
The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical Aspects. Cancers (Basel) (2013) 0.76
A novel function of HER2/Neu in the activation of G2/M checkpoint in response to γ-irradiation. Oncogene (2014) 0.76
Erlotinib and concurrent chemoradiation in pretreated NSCLC patients: radiobiological basis and clinical results. Biomed Res Int (2013) 0.75
Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours. Br J Cancer (2014) 0.75
Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells. BMC Vet Res (2016) 0.75
Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment. Radiat Res (2016) 0.75
Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers. Indian J Med Res (2016) 0.75
Biological determinants of radioresistance and their remediation in pancreatic cancer. Biochim Biophys Acta (2017) 0.75
Mechanisms of skin aging induced by EGFR inhibitors. Support Care Cancer (2016) 0.75
Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate. Science (1993) 4.61
Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. J Biol Chem (2001) 2.37
Heterogeneity of virulence among strains of Bacteroides gingivalis. J Periodontal Res (1989) 1.99
Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res (2001) 1.98
Medical staffing in Ontario neonatal intensive care units. CMAJ (1989) 1.97
zeta PKC induces phosphorylation and inactivation of I kappa B-alpha in vitro. EMBO J (1994) 1.95
Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther (2001) 1.71
Characterization of infectivity of knob-modified adenoviral vectors in glioma. Cancer Biol Ther (2008) 1.61
Ordered phosphorylation of p42mapk by MAP kinase kinase. FEBS Lett (1992) 1.57
Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation. Mol Cell Biol (1996) 1.55
Autocrine loops with positive feedback enable context-dependent cell signaling. Am J Physiol Cell Physiol (2002) 1.55
Neutrophil plasma membranes. I. High-yield purification of human neutrophil plasma membrane vesicles by nitrogen cavitation and differential centrifugation. J Cell Biol (1980) 1.52
Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization. J Natl Cancer Inst (2001) 1.52
A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc Natl Acad Sci U S A (2001) 1.52
Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2. Mol Cell Biol (1993) 1.48
Identification, physical map location and sequence of the denV gene from bacteriophage T4. Nucleic Acids Res (1984) 1.46
Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. Biochem J (1993) 1.45
Biological effects of a purified lipopolysaccharide from Bacteroides gingivalis. J Periodontal Res (1983) 1.42
Soft tissue complication rates after low dose rate brachytherapy using customized perineal templates. Int J Radiat Oncol Biol Phys (1994) 1.39
Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells. Cancer Res (2001) 1.38
Signal transduction and cellular radiation responses. Radiat Res (2000) 1.32
Increased expression of complement component C3 in the plasma of obese Zucker fa and LA/N fa(f) rats compared with their lean counterparts. Obes Res (1998) 1.31
Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. Eur J Pharmacol (1999) 1.30
Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem (2001) 1.27
Activation of Raf by ionizing radiation. Nature (1996) 1.22
Genetic complementation of UV-induced DNA repair in Chinese hamster ovary cells by the denV gene of phage T4. Proc Natl Acad Sci U S A (1985) 1.21
Synergistic interactions between MEK1/2 and histone deacetylase inhibitors in BCR/ABL+ human leukemia cells. Leukemia (2005) 1.21
Differential regulation of the mitogen-activated protein and stress-activated protein kinase cascades by adrenergic agonists in quiescent and regenerating adult rat hepatocytes. Mol Cell Biol (1997) 1.17
Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.17
A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell (2000) 1.16
Sphingosine-1-phosphate phosphohydrolase-1 regulates ER stress-induced autophagy. Cell Death Differ (2010) 1.16
Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation. Mol Biol Cell (2001) 1.16
Effects of ethanol on mitogen-activated protein kinase and stress-activated protein kinase cascades in normal and regenerating liver. Biochem J (1998) 1.16
Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene (1999) 1.15
Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells. Cancer Gene Ther (2010) 1.13
Expression of a cloned denV gene of bacteriophage T4 in Escherichia coli. Proc Natl Acad Sci U S A (1985) 1.13
Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol Pharmacol (1997) 1.13
Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways. Oncogene (2001) 1.10
Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken) (2010) 1.10
Recurrent cervical carcinoma: typical and atypical manifestations. Radiographics (1999) 1.09
The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. Mol Biol Cell (1998) 1.09
The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2001) 1.08
Mitogen-activated protein kinase kinase 1 (MKK1) is negatively regulated by threonine phosphorylation. Mol Cell Biol (1994) 1.08
Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene (1998) 1.06
Activation of tat-defective human immunodeficiency virus by ultraviolet light. New Biol (1990) 1.06
PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells. Nucleic Acids Res (2001) 1.05
A cancer terminator virus eradicates both primary and distant human melanomas. Cancer Gene Ther (2008) 1.05
The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells. Oncogene (2001) 1.04
Molecular mechanisms of radiation-induced accelerated repopulation. Radiat Oncol Investig (1999) 1.04
Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys (2000) 1.03
Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression. Hepatology (2001) 1.03
Photoactivated cross-linking of proteins within the erythrocyte membrane core. J Biol Chem (1976) 1.02
An investigation into the structural determinants of cannabinoid receptor ligand efficacy. Br J Pharmacol (1999) 1.00
Distinctive gene expression profiles associated with Hepatitis B virus x protein. Oncogene (2001) 1.00
Comparison of adenylate cyclase and cAMP-dependent protein kinase in gametocytogenic and nongametocytogenic clones of Plasmodium falciparum. J Parasitol (1991) 1.00
Calcium transport of Plasmodium chabaudi-infected erythrocytes. J Cell Biol (1982) 1.00
Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor. Clin Cancer Res (2001) 1.00
Regulation of mda-7 gene expression during human melanoma differentiation. Oncogene (2000) 0.99
Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice. Biochem J (1998) 0.98
Targetting of protein phosphatase 1 to the sarcoplasmic reticulum of rabbit skeletal muscle by a protein that is very similar or identical to the G subunit that directs the enzyme to glycogen. Eur J Biochem (1990) 0.98
Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Mol Cell Biol (1997) 0.97
Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. Radiat Res (1996) 0.97
Functional mapping of the N-terminal regulatory domain in the human Raf-1 protein kinase. J Biol Chem (1995) 0.97
Membrane potential of Plasmodium-infected erythrocytes. J Cell Biol (1982) 0.97
AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation. J Cell Physiol (2000) 0.95
Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling. Mol Pharmacol (1998) 0.95
Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation. J Neurochem (2001) 0.94
Activation of Ras/Raf protects cells from melanoma differentiation-associated gene-5-induced apoptosis. Cell Death Differ (2006) 0.94
A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin. Cancer Res (2001) 0.94
The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells. Clin Cancer Res (1999) 0.93
High affinity calcium binding sites on erythrocyte membrane proteins. Use of lanthanides as fluorescent probes. Biochim Biophys Acta (1974) 0.93
Overexpression of CYP27 in hepatic and extrahepatic cells: role in the regulation of cholesterol homeostasis. Am J Physiol Gastrointest Liver Physiol (2001) 0.91
The MPM-2 antibody inhibits mitogen-activated protein kinase activity by binding to an epitope containing phosphothreonine-183. Mol Biol Cell (1994) 0.91
Membrane potential of erythrocytic stages of Plasmodium chabaudi free of the host cell membrane. Mol Biochem Parasitol (1986) 0.91